| pubmed-article:21386832 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21386832 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:21386832 | lifeskim:mentions | umls-concept:C0009324 | lld:lifeskim |
| pubmed-article:21386832 | lifeskim:mentions | umls-concept:C0010592 | lld:lifeskim |
| pubmed-article:21386832 | lifeskim:mentions | umls-concept:C0666743 | lld:lifeskim |
| pubmed-article:21386832 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:21386832 | pubmed:dateCreated | 2011-4-6 | lld:pubmed |
| pubmed-article:21386832 | pubmed:abstractText | Rescue therapy with either cyclosporine (CYS) or infliximab (IFX) is an effective option in patients with intravenous steroid-refractory attacks of ulcerative colitis (UC). In patients who fail, colectomy is usually recommended, but a second-line rescue therapy with IFX or CYS is an alternative. The aims of this study were to investigate the efficacy and tolerance of IFX and CYS as a second-line rescue therapy in steroid-refractory UC or indeterminate colitis (IC) unsuccessfully treated with CYS or IFX. | lld:pubmed |
| pubmed-article:21386832 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21386832 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21386832 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21386832 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21386832 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21386832 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21386832 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21386832 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21386832 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21386832 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:21386832 | pubmed:issn | 1572-0241 | lld:pubmed |
| pubmed-article:21386832 | pubmed:author | pubmed-author:MichettiPP | lld:pubmed |
| pubmed-article:21386832 | pubmed:author | pubmed-author:PeetersHH | lld:pubmed |
| pubmed-article:21386832 | pubmed:author | pubmed-author:DupasJ LJL | lld:pubmed |
| pubmed-article:21386832 | pubmed:author | pubmed-author:MaryJ YJY | lld:pubmed |
| pubmed-article:21386832 | pubmed:author | pubmed-author:ChaussadeSS | lld:pubmed |
| pubmed-article:21386832 | pubmed:author | pubmed-author:ColombelJ FJF | lld:pubmed |
| pubmed-article:21386832 | pubmed:author | pubmed-author:FlouriéBB | lld:pubmed |
| pubmed-article:21386832 | pubmed:author | pubmed-author:DuclosBB | lld:pubmed |
| pubmed-article:21386832 | pubmed:author | pubmed-author:LémannMM | lld:pubmed |
| pubmed-article:21386832 | pubmed:author | pubmed-author:BouhnikYY | lld:pubmed |
| pubmed-article:21386832 | pubmed:author | pubmed-author:DewitOO | lld:pubmed |
| pubmed-article:21386832 | pubmed:author | pubmed-author:LeblancSS | lld:pubmed |
| pubmed-article:21386832 | pubmed:author | pubmed-author:AlleyNN | lld:pubmed |
| pubmed-article:21386832 | pubmed:author | pubmed-author:BourreilleAA | lld:pubmed |
| pubmed-article:21386832 | pubmed:author | pubmed-author:SeksikPP | lld:pubmed |
| pubmed-article:21386832 | pubmed:author | pubmed-author:GETAID | lld:pubmed |
| pubmed-article:21386832 | pubmed:author | pubmed-author:Peyrin-Biroul... | lld:pubmed |
| pubmed-article:21386832 | pubmed:author | pubmed-author:BouguenGG | lld:pubmed |
| pubmed-article:21386832 | pubmed:author | pubmed-author:SaussurePP | lld:pubmed |
| pubmed-article:21386832 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21386832 | pubmed:volume | 106 | lld:pubmed |
| pubmed-article:21386832 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21386832 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21386832 | pubmed:pagination | 771-7 | lld:pubmed |
| pubmed-article:21386832 | pubmed:meshHeading | pubmed-meshheading:21386832... | lld:pubmed |
| pubmed-article:21386832 | pubmed:meshHeading | pubmed-meshheading:21386832... | lld:pubmed |
| pubmed-article:21386832 | pubmed:meshHeading | pubmed-meshheading:21386832... | lld:pubmed |
| pubmed-article:21386832 | pubmed:meshHeading | pubmed-meshheading:21386832... | lld:pubmed |
| pubmed-article:21386832 | pubmed:meshHeading | pubmed-meshheading:21386832... | lld:pubmed |
| pubmed-article:21386832 | pubmed:meshHeading | pubmed-meshheading:21386832... | lld:pubmed |
| pubmed-article:21386832 | pubmed:meshHeading | pubmed-meshheading:21386832... | lld:pubmed |
| pubmed-article:21386832 | pubmed:meshHeading | pubmed-meshheading:21386832... | lld:pubmed |
| pubmed-article:21386832 | pubmed:meshHeading | pubmed-meshheading:21386832... | lld:pubmed |
| pubmed-article:21386832 | pubmed:meshHeading | pubmed-meshheading:21386832... | lld:pubmed |
| pubmed-article:21386832 | pubmed:meshHeading | pubmed-meshheading:21386832... | lld:pubmed |
| pubmed-article:21386832 | pubmed:meshHeading | pubmed-meshheading:21386832... | lld:pubmed |
| pubmed-article:21386832 | pubmed:meshHeading | pubmed-meshheading:21386832... | lld:pubmed |
| pubmed-article:21386832 | pubmed:meshHeading | pubmed-meshheading:21386832... | lld:pubmed |
| pubmed-article:21386832 | pubmed:meshHeading | pubmed-meshheading:21386832... | lld:pubmed |
| pubmed-article:21386832 | pubmed:meshHeading | pubmed-meshheading:21386832... | lld:pubmed |
| pubmed-article:21386832 | pubmed:meshHeading | pubmed-meshheading:21386832... | lld:pubmed |
| pubmed-article:21386832 | pubmed:meshHeading | pubmed-meshheading:21386832... | lld:pubmed |
| pubmed-article:21386832 | pubmed:meshHeading | pubmed-meshheading:21386832... | lld:pubmed |
| pubmed-article:21386832 | pubmed:meshHeading | pubmed-meshheading:21386832... | lld:pubmed |
| pubmed-article:21386832 | pubmed:meshHeading | pubmed-meshheading:21386832... | lld:pubmed |
| pubmed-article:21386832 | pubmed:meshHeading | pubmed-meshheading:21386832... | lld:pubmed |
| pubmed-article:21386832 | pubmed:meshHeading | pubmed-meshheading:21386832... | lld:pubmed |
| pubmed-article:21386832 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21386832 | pubmed:articleTitle | Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis. | lld:pubmed |
| pubmed-article:21386832 | pubmed:affiliation | Hôpital Saint-Louis, Université Paris-Diderot, Assistance Publique-Hôpitaux de Paris, Paris, France. | lld:pubmed |
| pubmed-article:21386832 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21386832 | pubmed:publicationType | Multicenter Study | lld:pubmed |
